A closer examination of some of these genes might reveal intricacies in the interactions of PTHR1 and PTH-derived treatments just as further delineation of which events are attributable to signaling mechanisms triggered by PTH (1-34), PTHrP (1-36), and ABL would allow for further refining of future treatments for osteoporosis. The gene discussed is PTH1R; the disease is osteoporosis.